Avalon GloboCareALBT
ALBT
About: Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Employees: 5
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
4% more capital invested
Capital invested by funds: $52K [Q3] → $54K (+$1.92K) [Q4]
0.04% less ownership
Funds ownership: 1.57% [Q3] → 1.53% (-0.04%) [Q4]
47% less funds holding
Funds holding: 15 [Q3] → 8 (-7) [Q4]
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Research analyst outlook
We haven’t received any recent analyst ratings for ALBT.
Financial journalist opinion
Neutral
PRNewsWire
1 month ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN and ALBT on Behalf of Shareholders
NEW YORK , March 12, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Nordstrom, Inc. (NYSE: JWN)'s sale to Erik, Pete, Jamie Nordstrom and other members of the Nordstrom family and El Puerto de Liverpool, S.A.B. de C.V. for $24.25 in cash per share.
Neutral
Business Wire
1 month ago
ALBT Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Avalon GloboCare Corp. is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Avalon GloboCare Corp. (NASDAQ: ALBT) and YOOV Group Holding Limited is fair to Avalon shareholders. Upon closing of the proposed transaction, Avalon shareholders are expected to own between approximately 2.5% to 2.2% of the common stock of the combined company. Halper Sadeh encourages Avalon shareholders to click here to learn more about their legal rights and options or contact Dan.
Neutral
PRNewsWire
1 month ago
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Avalon GloboCare Corp. - ALBT
NEW YORK , March 10, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Avalon GloboCare Corp. (NASDAQ: ALBT ), relating to the proposed merger with YOOV Group Holding Limited.
Neutral
Business Wire
1 month ago
Shareholder Alert: The Ademi Firm investigates whether Avalon GloboCare Corp. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Avalon (Nasdaq: ALBT) for possible breaches of fiduciary duty and other violations of law in its transaction with YOOV. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the reverse merger transaction, Avalon stockholders are expected to collectively own between approximately 2.5% to 2.2% and YOOV.
Neutral
GlobeNewsWire
4 months ago
Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device
FREEHOLD, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and laboratory services, today announced the launch of the "BrAce for Impact" affiliate marketing program for KetoAir™, a handheld breathalyzer device equipped with AI-enabled software and Hot App shareable technology, specifically designed for ketogenic health monitoring.
Neutral
GlobeNewsWire
5 months ago
Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving
FREEHOLD, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and laboratory services, today announced that it entered into a memorandum of understanding (the “MOU”) with Qi Diagnostics Limited (“Qi Diagnostics”), a nanosensor-based diagnostic technologies company, to explore a proposed strategic collaboration to co-develop a VOC (volatile organic compound) nanosensor-based point-of-care cannabis breathalyzer. The MOU provides Avalon with an exclusivity period of 120 days (the “Exclusivity Period”), during which Avalon intends to negotiate with Qi Diagnostics and enter into a definitive agreement regarding the proposed strategic collaboration.
Positive
InvestorPlace
8 months ago
Why Is Avalon GloboCare (ALBT) Stock Up 173% Today?
Avalon GloboCare (NASDAQ: ALBT ) stock is up on Wednesday alongside news of a new medical device being launched by Laboratory Services MSO. Laboratory Services MSO is preparing to launch its GeeWhiz External Condom Catheter in the third quarter of 2024.
Neutral
GlobeNewsWire
8 months ago
Avalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction
Direct-To-Consumer, Non-Invasive Kit is Available in the U.S. for Convenient At-Home Sample Collection Direct-To-Consumer, Non-Invasive Kit is Available in the U.S. for Convenient At-Home Sample Collection
Positive
Proactive Investors
9 months ago
Avalon GloboCare unveils KetoAir breathalyzer at KetoCon 2024
Avalon GloboCare Corp (NASDAQ:ALBT) said it had successfully launched its KetoAir breathalyzer in the US at the Hack Your Health by KetoCon 2024 Conference. Avalon CEO David Jin told shareholders that the booth at the event in Austin “attracted a diverse group of potential clients and partners, including doctors, disease management companies, health and keto coaches, consumers, keto product manufacturers, and service providers interested in establishing a marketplace on our app and device.
Neutral
InvestorPlace
10 months ago
Why Is Avalon Globocare (ALBT) Stock Down 27% Today?
Avalon Globocare (NASDAQ: ALBT ) stock is down on Tuesday but only after the commercial real estate company's shares underwent a massive rally on Monday on a recent filing. That rally came after the company filed its Form 10-Q with the Securities and Exchange Commission (SEC).
Charts implemented using Lightweight Charts™